Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 30:18:1408189.
doi: 10.3389/fncir.2024.1408189. eCollection 2024.

Endogenous opioids in the olfactory tubercle and their roles in olfaction and quality of life

Affiliations
Review

Endogenous opioids in the olfactory tubercle and their roles in olfaction and quality of life

Koshi Murata et al. Front Neural Circuits. .

Abstract

Olfactory dysfunctions decrease daily quality of life (QOL) in part by reducing the pleasure of eating. Olfaction plays an essential role in flavor sensation and palatability. The decreased QOL due to olfactory dysfunction is speculated to result from abnormal neural activities in the olfactory and limbic areas of the brain, as well as peripheral odorant receptor dysfunctions. However, the specific underlying neurobiological mechanisms remain unclear. As the olfactory tubercle (OT) is one of the brain's regions with high expression of endogenous opioids, we hypothesize that the mechanism underlying the decrease in QOL due to olfactory dysfunction involves the reduction of neural activity in the OT and subsequent endogenous opioid release in specialized subregions. In this review, we provide an overview and recent updates on the OT, the endogenous opioid system, and the pleasure systems in the brain and then discuss our hypothesis. To facilitate the effective treatment of olfactory dysfunctions and decreased QOL, elucidation of the neurobiological mechanisms underlying the pleasure of eating through flavor sensation is crucial.

Keywords: brain reward system; dopamine; olfactory tubercle; opioid; preproenkephalin; prodynorphin; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
Pdyn-Penk co-expressing D1 neurons in the mouse OT. (A) Single probe in situ hybridization for Pdyn, Penk, Drd1, and Drd2. The pictures show coronal sections of the anterior OT and NAc (approximately at Bregma +1.94 mm). Regions delineated by red lines are a cluster of Pdyn-Penk-Drd1 co-expressing cells. Drd2 signals were not observed in the cluster. Adjacent sections from one mouse were used for the four images. (B) Triple fluorescence in situ hybridization for Pdyn, Penk, and Drd1 in the anteromedial OT. White arrowheads indicate the colocalization of Pdyn-Penk-Drd1 mRNAs. D, dorsal; V, ventral; M, medial; L, lateral. Figures are modified from Maegawa et al. (2022).
Figure 2
Figure 2
A hypothetical model of OT opioid-mediated QOL and its impairment due olfactory dysfunctions. In a healthy condition, food-related olfactory inputs, including food odorants via the retronasal pathway, are conveyed to the anteromedial OT, where Pdyn-expressing and Pdyn-Penk-coexpressing D1 neurons are activated. Subsequently, opioid peptides are released from D1 neurons in the anteromedial OT, resulting in hedonic pleasure sensation. In some cases of olfactory dysfunctions, the retronasal airflow is blocked, inhibiting the transmission of the olfactory inputs to the anteromedial OT. This, in turn, impairs neural activation and opioid release of the anteromedial OT, which reduces the sensation of pleasure. Red circles, Pdyn-expressing D1 neurons; green circles, Pdyn-Penk-coexpressing D1 neurons; blue circles, Penk-expressing neurons D2. OTam, anteromedial olfactory tubercle; OTal, anterolateral olfactory tubercle; NAc, nucleus accumbens; VP, ventral pallidum; D, dorsal; V, ventral; M, medial; L, lateral. Stereotax atlas from Franklin and Paxinos (2008).

Similar articles

Cited by

References

    1. Al-Hasani R., Wong J.-M. T., Mabrouk O. S., McCall J. G., Schmitz G. P., Porter-Stransky K. A., et al. . (2018). In vivo detection of optically-evoked opioid peptide release. eLife 7:e36520. doi: 10.7554/eLife.36520, PMID: - DOI - PMC - PubMed
    1. Allison A. C. (1954). The secondary olfactory areas in the human brain. J. Anat. 88, 481–488, PMID: - PMC - PubMed
    1. Barbano M. F., Cador M. (2007). Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology 191, 497–506. doi: 10.1007/s00213-006-0521-1, PMID: - DOI - PubMed
    1. Berendse H. W., Galis-de Graaf Y., Groenewegen H. J. (1992). Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J. Comp. Neurol. 316, 314–347. doi: 10.1002/cne.903160305, PMID: - DOI - PubMed
    1. Berridge K. C. (2000). Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci. Biobehav. Rev. 24, 173–198. doi: 10.1016/S0149-7634(99)00072-X, PMID: - DOI - PubMed

Substances